ESC 365 - Evaluation of a new automated screening tool for the assessment of the eligibility for a subcutaneous implantable-cardioverter defibrillator

EHRA Premium Access

Evaluation of a new automated screening tool for the assessment of the eligibility for a subcutaneous implantable-cardioverter defibrillator

Session: Poster session 2 - Subcutaneous ICD

Topic: Implantable Cardioverter / Defibrillator

Speaker: Mr R. Sakhi (Rotterdam, NL)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Mr Rafi Sakhi

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

0 follower

9 more presentations in this session

Eligibility of CRT Patients for Subcutaneous Implantable Cardioverter Defibrillators

Insight into screening results and post-implantation exercise testing in recipients of a subcutaneous Implantable cardioverter defibrillator

Speaker: Doctor N. Dayal (Geneva, CH)

Universal S-ICD eligibility: eliminating the need for pre-implant screening using mathematical vector rotation and a gradient filter

Speaker: Doctor B. Wiles (London, GB)

Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: a single center italian experience

Speaker: Professor F. Migliore (Padova, IT)

Optimization of cardiac resynchronization therapy device selection guided by cardiac magnetic resonance imaging is cost-effective

Speaker: Doctor M. Linhart (Barcelona, ES)

Access the full session

Poster session 2 - Subcutaneous ICD

Speakers: Mr R. Sakhi, Doctor N. Dayal, Doctor B. Wiles, Professor F. Migliore, Doctor M. Linhart

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources